CRIS vs CLDX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

CRIS

48.6
AI Score
VS
CRIS Wins

CLDX

44.8
AI Score

Investment Advisor Scores

CRIS

49score
Recommendation
HOLD

CLDX

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRIS CLDX Winner
Net Income -32.78M -152.19M CRIS
Operating Income -21.46M -165.06M CRIS
ROE -698.2% -21.3% CLDX
ROA -172.8% -19.5% CLDX
Total Assets 18.97M 782.35M CLDX
Cash 5.07M 47.45M CLDX
Current Ratio 0.49 11.82 CLDX

Relative Price Performance (Last 90 Days)

CRIS 1M: -32.3% · 3M: +164.9% CLDX 1M: -17.8% · 3M: +23.2%

Current Technical Phase

CRIS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 22

RSI (14): 22.3 · Price: $1.13

CLDX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.9 · Price: $36.90

Fundamentals Snapshot

Metric CRIS CLDX
Market Cap
Forward P/E -0.2 -8.8
Trailing P/E 0.3
Revenue (TTM)
Revenue Growth -0.7% -1.0%
Gross Margin -4.9% -1763.6%
Operating Margin -8.3% -3664.7%
EPS 3.65 -4.28
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRIS is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.